Prolonged response to osimertinib in three patients with refractory metastatic pancreatic adenocarcinomas with exon 19 deletion: a case report and literature review
Pancreatic cancer is a rising cause of cancer death. Therapeutic options are scarce and of limited efficacy. Up to 26% of patients with metastatic pancreatic cancer could benefit from targeted therapies. We report here for the first time the case of three patients with metastatic pancreatic ductal a...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publishing
2025-03-01
|
| coleção: | Therapeutic Advances in Medical Oncology |
| Acesso em linha: | https://doi.org/10.1177/17588359241312078 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|